Table A1.

Summary of datasets used to assess performance of active learning and recall estimation methods.

Dataset	Source	Label Type	Records from Search	Included	Excluded
PFOA/PFOS and immunotoxicity	NIEHS	Full text	6331	95 (1.5%)	6236 (98.5%)
Bisphenol A (BPA) and obesity	NIEHS	Full text	7700	111 (1.4%)	7589 (98.6%)
Transgenerational inheritance of health effects	NIEHS	Tiab	48,638	765 (1.6%)	47,873 (98.4%)
Fluoride and neurotoxicity in animal models	NIEHS	Full text	4479	51 (1.1%)	4428 (98.9%)
Neuropathic pain	CAMARADES	Tiab	29,207	5011 (17.2%)	24,196 (82.8%)
Skeletal muscle relaxants	Cohen (2006)	Full Text	1643	9 (0.6%)	1634 (99.4%)
Opioids	Cohen (2006)	Full Text	1915	15 (0.8%)	1900 (99.2%)
Antihistamines	Cohen (2006)	Full Text	310	16 (5.2%)	294 (94.8%)
ADHD	Cohen (2006)	Full Text	851	20 (2.4%)	831 (97.6%)
Triptans	Cohen (2006)	Full text	671	24 (3.6%)	647 (96.4%)
Urinary Incontinence	Cohen (2006)	Full text	327	40 (12.2%)	287 (87.8%)
Ace Inhibitors	Cohen (2006)	Full text	2544	41 (1.6%)	2503 (98.4%)
Nonsteroidal anti-inflammatory	Cohen (2006)	Full text	393	41 (10.4%)	352 (89.6%)
Beta blockers	Cohen (2006)	Full text	2072	42 (2.0%)	2030 (98.0%)
Proton pump inhibitors	Cohen (2006)	Full text	1333	51 (3.8%)	1282 (96.2%)
Estrogens	Cohen (2006)	Full text	368	80 (21.7%)	288 (78.3%)
Statins	Cohen (2006)	Full text	3465	85 (2.5%)	3380 (97.5%)
Calcium-channel blockers	Cohen (2006)	Full text	1218	100 (8.2%)	1118 (91.8%)
Oral hypoglycemics	Cohen (2006)	Full text	503	136 (27.0%)	367 (73.0%)
Atypical antipsychotics	Cohen (2006)	Full text	1120	146 (13.0%)	974 (87.0%)
Mammalian	EBTC	Tiab	1442	263 (18.2%)	1179 (81.8%)
USDA 1	USDA	Tiab	1776	225 (12.7%)	1551 (87.3%)
USDA 2	USDA	Tiab	9103	382 (4.2%)	8721 (95.8%)
USDA 3	USDA	Tiab	608	9 (1.5%)	599 (98.5%)
USDA 4	USDA	Tiab	104	12 (11.5%)	92 (88.5%)
USDA 5	USDA	Tiab	1570	25 (1.6%)	1545 (98.4%)